Aconitum carmichaelii Debx. Attenuates Heart Failure through Inhibiting Inflammation and Abnormal Vascular Remodeling

Ziwei Xing1, Junren Chen1, Tingting Yu1

  • 1State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.

Insights

A water extract of toasted Aconitum carmichaelii Debx. (WETA) protects against heart failure (HF) in rats by reducing inflammation and abnormal vascular remodeling. This traditional Chinese herb shows promise for treating myocardial infarction complications.

Area of Science:

  • Cardiovascular Research
  • Pharmacology
  • Traditional Chinese Medicine

Background:

  • Heart failure (HF) is a primary complication of myocardial infarction, linked to ventricular remodeling.
  • Aconitum carmichaelii Debx. is a traditional Chinese herb with potential therapeutic effects on HF, but its mechanisms remain unclear.

Purpose of the Study:

  • To investigate the protective effects and underlying mechanisms of a water extraction of toasted Aconitum carmichaelii Debx. (WETA) on isoproterenol (ISO)-induced heart failure in rats.

Main Methods:

  • WETA was characterized using UPLC-Q/TOF-MS.
  • Cardiac function and injury were assessed via echocardiography, serum markers (CK-MB, cTnT, cTnI), and tissue staining (TTC, H&E, Masson's trichrome).
  • Inflammation and vascular remodeling markers were quantified using RT-qPCR, Western blot, and immunofluorescence.

Main Results:

  • WETA significantly improved echocardiographic parameters and reduced heart weight, infarct size, myonecrosis, edema, and collagen deposition in ISO-induced HF rats.
  • WETA lowered elevated serum levels of cardiac injury markers (CK-MB, cTnT, cTnI).
  • WETA suppressed inflammatory gene expression (IL-1β, IL-6, TNF-α) and vascular remodeling markers (VCAM1, ICAM1, ANP, BNP, MHC) in heart tissues.

Conclusions:

  • WETA demonstrates significant myocardial protective effects in ISO-treated rats.
  • These protective effects are attributed to the inhibition of inflammatory responses and abnormal vascular remodeling.
  • WETA holds potential as a therapeutic agent for HF associated with myocardial infarction.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
478
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
407
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
14
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
435
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
20
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
659